Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950157-10-001785
Filing Date
2010-09-17
Accepted
2010-09-16 21:04:58
Documents
6

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d.htm SC 13D 104854
2 EQUITY PURCHASE AGREEMENT ex-1.htm EX-1 780488
3 SHAREHOLDER AGREEMENT ex-2.htm EX-2 311411
4 REGISTRATION RIGHTS AGREEMENT ex-3.htm EX-3 171940
5 PRESS RELEASE ex-4.htm EX-4 30529
6 johnson_crucell.jpg GRAPHIC 10867
  Complete submission text file 0000950157-10-001785.txt   1416469
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0209
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address CT CORPORATION SYSTEM 111 EIGTH AVE 13TH FL NEW YORK NY 10011
Business Address ARCHIMEDESWEG 4 2333 CN LEIDEN THE NETHERLANDS P8 00000
CRUCELL NV (Subject) CIK: 0001126136 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-51066 | Film No.: 101077100
SIC: 8731 Services-Commercial Physical & Biological Research